Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.93
+0.02 (0.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Accolade Employees
Accolade had 2,400 employees as of February 29, 2024. The number of employees increased by 30 or 1.27% compared to the previous year.
Employees
2,400
Change (1Y)
30
Growth (1Y)
1.27%
Revenue / Employee
$186,133
Profits / Employee
-$75,124
Market Cap
565.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ACCD News
- 18 days ago - Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PRNewsWire
- 6 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade - PRNewsWire
- 6 weeks ago - ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD - Business Wire
- 6 weeks ago - Why Is Accolade Stock Trading Over 100% On Tuesday? - Benzinga
- 6 weeks ago - Healthcare M&A: Transcarent paying $621M to acquire Seattle-based health benefits firm Accolade - GeekWire
- 6 weeks ago - Transcarent To Acquire Accolade - Business Wire
- 2 months ago - Accolade to Announce Fiscal Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Accolade: A GARP Stock Trading Well Under 1X Revenues - Seeking Alpha